Hamzeh Albaba

829 total citations
11 papers, 152 citations indexed

About

Hamzeh Albaba is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hamzeh Albaba has authored 11 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hamzeh Albaba's work include Cancer Genomics and Diagnostics (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Hamzeh Albaba is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Hamzeh Albaba collaborates with scholars based in Canada, United States and Jordan. Hamzeh Albaba's co-authors include Catherine Labbé, Grainne M. O’Kane, Mark Doherty, Natasha B. Leighl, Samer Salah, Geoffrey Liu, Nicole Mittmann, Doris Howell, Lawson Eng and Susie Su and has published in prestigious journals such as Journal of Clinical Oncology, The Oncologist and Lung Cancer.

In The Last Decade

Hamzeh Albaba

8 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamzeh Albaba Canada 6 113 67 38 29 17 11 152
Wei‐Sen Lam Australia 7 107 0.9× 143 2.1× 17 0.4× 20 0.7× 13 0.8× 15 230
Merete Krogh Denmark 6 195 1.7× 70 1.0× 31 0.8× 19 0.7× 27 1.6× 17 233
Seigo Sasaki Japan 4 289 2.6× 153 2.3× 32 0.8× 14 0.5× 36 2.1× 8 326
Jennifer Arena Australia 8 173 1.5× 59 0.9× 64 1.7× 21 0.7× 61 3.6× 15 194
B.E. van den Borne Netherlands 6 103 0.9× 99 1.5× 37 1.0× 6 0.2× 10 0.6× 10 210
José Luis Manzano Mozo Spain 5 155 1.4× 33 0.5× 62 1.6× 40 1.4× 22 1.3× 15 176
Prerna Guleria India 8 55 0.5× 30 0.4× 29 0.8× 32 1.1× 53 3.1× 25 149
Nieves Martínez Lago Spain 8 121 1.1× 51 0.8× 18 0.5× 8 0.3× 12 0.7× 44 165
Sara Manglaviti Italy 7 72 0.6× 59 0.9× 14 0.4× 15 0.5× 8 0.5× 23 136
Ridhi Gupta United States 6 43 0.4× 46 0.7× 10 0.3× 12 0.4× 40 2.4× 14 166

Countries citing papers authored by Hamzeh Albaba

Since Specialization
Citations

This map shows the geographic impact of Hamzeh Albaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamzeh Albaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamzeh Albaba more than expected).

Fields of papers citing papers by Hamzeh Albaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamzeh Albaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamzeh Albaba. The network helps show where Hamzeh Albaba may publish in the future.

Co-authorship network of co-authors of Hamzeh Albaba

This figure shows the co-authorship network connecting the top 25 collaborators of Hamzeh Albaba. A scholar is included among the top collaborators of Hamzeh Albaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamzeh Albaba. Hamzeh Albaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Albaba, Hamzeh, Anna Dodd, Osvaldo Espin‐Garcia, et al.. (2024). Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort Study. Current Oncology. 31(5). 2589–2597.
2.
Fung, Andrea S., Donna M. Graham, Eric X. Chen, et al.. (2021). A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer. Lung Cancer. 157. 21–29. 9 indexed citations
3.
Veitch, Zachary, Philippe L. Bédard, Patricia A. Tang, et al.. (2019). Clinical characteristics of patients with no evidence of disease (NED) versus residual disease (RES) to anti-HER2 therapy in metastatic breast cancer (MBC): A multi-institutional analysis.. Journal of Clinical Oncology. 37(15_suppl). 1034–1034. 1 indexed citations
4.
5.
Aung, Kyaw, Sandra E. Fischer, Gun Ho Jang, et al.. (2018). Genomics-driven precision medicine for advanced pancreatic ductal carcinoma (PDAC): Early results from the COMPASS trial (NCT02750657).. Journal of Clinical Oncology. 36(4_suppl). 211–211.
6.
Albaba, Hamzeh, et al.. (2017). Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature. PharmacoEconomics. 35(12). 1195–1209. 19 indexed citations
7.
8.
O’Kane, Grainne M., et al.. (2016). Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer. The Oncologist. 22(1). 70–80. 53 indexed citations
9.
Albaba, Hamzeh, Andrea Bezjak, & Natasha B. Leighl. (2016). Quality of life (QoL) for FDA-approved agents in advanced NSCLC.. Journal of Clinical Oncology. 34(15_suppl). e18117–e18117.
10.
Albaba, Hamzeh, et al.. (2014). Efficacy of Capecitabine and Temozolomide Combination in Well-Differentiated Neuroendocrine Tumors. Pancreas. 43(8). 1303–1305. 31 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐Sen Lam Breakdown of academic impact, for papers by Merete Krogh Breakdown of academic impact, for papers by Seigo Sasaki Breakdown of academic impact, for papers by Jennifer Arena Breakdown of academic impact, for papers by B.E. van den Borne Breakdown of academic impact, for papers by José Luis Manzano Mozo Breakdown of academic impact, for papers by Prerna Guleria Breakdown of academic impact, for papers by Nieves Martínez Lago Breakdown of academic impact, for papers by Sara Manglaviti Breakdown of academic impact, for papers by Ridhi Gupta
Rankless by CCL
2026